Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Interest & Investment Income (2023 - 2025)

Incannex Healthcare's Interest & Investment Income history spans 3 years, with the latest figure at $1000.0 for Q2 2025.

  • For Q2 2025, Interest & Investment Income fell 97.5% year-over-year to $1000.0; the TTM value through Jun 2025 reached $62000.0, down 69.9%, while the annual FY2025 figure was $62000.0, 69.9% down from the prior year.
  • Interest & Investment Income for Q2 2025 was $1000.0 at Incannex Healthcare, down from $4000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $75000.0 in Q1 2024 and bottomed at $1000.0 in Q2 2025.
  • The 3-year median for Interest & Investment Income is $28500.0 (2024), against an average of $33500.0.
  • The largest annual shift saw Interest & Investment Income soared 45.0% in 2024 before it tumbled 97.5% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $20000.0 in 2023, then soared by 45.0% to $29000.0 in 2024, then crashed by 96.55% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Interest & Investment Income are $1000.0 (Q2 2025), $4000.0 (Q1 2025), and $29000.0 (Q4 2024).